Tomorrow's Cell
Therapies, Today®

Pluristyx provides the expertise and tools

to support and accelerate the development and commercialization of revolutionary therapeutics.

We Simplify the Stem Cell Therapy

Development Process

Derivation
Gene Editing
Product
Banking
Expansion

We Simplify the Stem Cell Therapy

Development Process

Derivation
Gene Editing
Product
Banking
Expansion

Why Pluristyx, powered by panCELLa?

Through the panCELLa platform, Pluristyx provides the expertise and tools to support and accelerate the development and commercialization of revolutionary therapeutics.

End-to-End Solutions

With our enlarged portfolio of unique non-modified and genetically engineered iPSC-based technologies, we can assist you at any stage in your product development workflow.

Gene Edits

Offering an array of gene editing technologies resulting in unparalleled functional control of commercial products.

Clinical Path iPSC

Leading provider of gene-edited iPSC and cell therapy solutions, accelerating the path to clinic and providing the best route to commercialization. 

Scientific Expertise

Veteran expertise from industry leaders in the field of stem cell biology developmental genetics and cell therapy.   

End-to-End Solutions

With our enlarged portfolio of unique non-modified and genetically engineered iPSC-based technologies, we can assist you at any stage in your product development workflow.

Gene Edits

Offering an array of gene editing technologies resulting in unparalleled functional control of commercial products.

Clinical Path iPSC

Leading provider of gene-edited iPSC and cell therapy solutions, accelerating the path to clinic and providing the best route to commercialization. 

Scientific Expertise

We have over 50 years of executive experience in development and manufacturing.  

Try Before You Buy

Would you like to experience our technology firsthand before committing to a license agreement We welcome you to have access to our various product offerings before you purchase a commercial license. 

Your Problems,
Our Solutions

To overcome any obstacle you’re facing, panCELLa, a novel platform for rapid, efficacious, and high-quality iPSC therapy development, can turn your bold ideas into reality.  

Your Problems, Our Solutions

To overcome any obstacle you’re facing, panCELLa, a novel platform for rapid, efficacious, and high-quality iPSC therapy development, can turn your bold ideas into reality.  

About Pluristyx​

Pluristyx, powered by panCELLa offers an enlarged portfolio of unique and effective non-modified and genetically engineered iPSC-based technologies and related services to provide end-to-end client support throughout the product lifecycle.  

About Pluristyx​

Pluristyx powered by panCELLa offers an enlarged portfolio of unique and effective non-modified and genetically engineered iPSC-based technologies and related services to provide end-to-end client support throughout the product lifecycle.  

About Pluristyx​

Pluristyx powered by panCELLa offers an enlarged portfolio of unique and effective non-modified and genetically engineered iPSC-based technologies and related services to provide end-to-end client support throughout the product lifecycle.  

Latest News​

Stem Genomics Announces Partnership with Pluristyx, Leading One-Stop-Shop Solution Provider for High-Quality Cell-Based Therapies. 

Pluristyx, Inc. and Stem Genomics SAS today announce the closing of an equity investment and strategic partnership in Stem Genomics. Through the partnership, the companies will offer a unified pathway to allow customers to evaluate the genomic stability of Pluristyx’s pluripotent...

Pluristyx and the Advanced Regenerative Manufacturing Institute to Commercialize Clinical-Grade Stem Cells

Pluristyx, Inc. today announced an agreement with the Advanced Regenerative Manufacturing Institute | BioFabUSA to manufacture and commercialize Pluristyx’s clinical-grade reprogrammed induced Pluripotent Stem Cells (iPSCs). This collaboration will make it possible to accelerate the scalable, consistent, and cost-effective manufacturing of stem cell derived...

Pluristyx/panCELLa Become Industry Resource Partner with the California Institute for Regenerative Medicine 

The partnership will improve access to clinical-grade genetically-modified induced pluripotent stem cells  June 12, 2023 – Seattle – Pluristyx and panCELLa, a merged biotechnology company with offices in Seattle, WA and Toronto, Ontario, CA, are excited to announce their acceptance...

Shopping Cart
Scroll to Top